Cisplatinum

She is now working with Hallahan to adapt her delivery system to carry cisplatinum, a traditional chemotherapy agent that is used to treat a number of different kinds of cancer but is highly toxic and has a number of unpleasant side effects. ❋ Unknown (2007)

"Accelerated fractionation concurrent with two doses of high dose cisplatinum has the potential to reduce toxicity related to the chemotherapy regimen by not exposing patients to a third cycle," said, Phuc Felix Nguyen-Tan, M.D., presenter of the study for the RTOG and assistant professor of radiation oncology at CHUM Notre-Dame in Montreal, Canada. ❋ Editors (2010)

An Article published Online First by The Lancet says that for patients with HER2-positive advanced gastric cancer, addition of tastuzumab to standard cisplatinum/fluoropyrimidine chemotherapy results in a median survival of 13.8 months, compared with 11.1 months with chemotherapy alone. ❋ Unknown (2010)

Dr. Williams, the H.H. Gregg Professor of Oncology at the IU School of Medicine, is a clinical researcher with national recognition for his expertise in the use of cisplatinum in the treatment of ovarian cancer. ❋ Unknown (2009)

Complete response rate at six months was 95. 4% in the cisplatinum arm, which did not differ from the 94. 5% rate with standard therapy. ❋ Unknown (2009)

(gemcitabine and cisplatinum) or standard of care alone, and will then undergo the previously planned bladder resection. ❋ Unknown (2010)